These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29563670)

  • 21. Antibody identification using both automated solid-phase red cell adherence assay and a tube polyethylene glycol antiglobulin method.
    Yamada C; Serrano-Rahman L; Vasovic LV; Mohandas K; Uehlinger J
    Transfusion; 2008 Aug; 48(8):1693-8. PubMed ID: 18482178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi, Kenya.
    Mangare C; Mbugua A; Maturi P; Rajab J; Blasczyk R; Heuft HG
    Afr J Lab Med; 2015; 4(1):297. PubMed ID: 28879098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody screening & identification in the general patient population at a tertiary care hospital in New Delhi, India.
    Makroo RN; Bhatia A; Hegde V; Chowdhry M; Thakur UK; Rosamma NL
    Indian J Med Res; 2014 Sep; 140(3):401-5. PubMed ID: 25366208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of solid-phase antibody screening tests with pooled red cells in blood donors.
    Schrem A; Flegel WA
    Vox Sang; 1996; 71(1):37-42. PubMed ID: 8837355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.
    Tormey CA; Fisk J; Stack G
    Transfusion; 2008 Oct; 48(10):2069-76. PubMed ID: 18631165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Group O blood donors in Iran: evaluation of isoagglutinin titers and immunoglobulin G subclasses.
    Arabi S; Moghaddam M; Pourfathollah AA; Aghaie A; Mosaed M
    Immunohematology; 2021 Mar; 37(1):5-12. PubMed ID: 33962489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility.
    Smith HM; Shirey RS; Thoman SK; Jackson JB
    Immunohematology; 2013; 29(4):127-30. PubMed ID: 24689681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Red cell alloimmunization in repeatedly transfused patients.
    Bhuva DK; Vachhani JH
    Asian J Transfus Sci; 2017; 11(2):115-120. PubMed ID: 28970677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency and specificity of red cell antibodies in thalassemia patients in Albania.
    Seferi I; Xhetani M; Face M; Burazeri G; Nastas E; Vyshka G
    Int J Lab Hematol; 2015 Aug; 37(4):569-74. PubMed ID: 25865362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence, Specificity and Titration of Red Cell Alloantibodies in Multiparous Antenatal Females at a Tertiary Care Centre from North India.
    Sidhu M; Bala R; Akhtar N; Sawhney V
    Indian J Hematol Blood Transfus; 2016 Sep; 32(3):307-11. PubMed ID: 27429523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of red cell alloimmunization in multi transfused patients at a Tertiary care teaching hospital.
    Handa A; Kukar N; Maharishi RN; Syal N; Arora H
    J Family Med Prim Care; 2020 Jun; 9(6):2907-2911. PubMed ID: 32984147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood group phenotype frequencies in blood donors from a tertiary care hospital in north India.
    Agarwal N; Thapliyal RM; Chatterjee K
    Blood Res; 2013 Mar; 48(1):51-4. PubMed ID: 23589796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a solid-phase test for erythrocyte antibody screening of pregnant women, patients and blood donors.
    Sallander S; Shanwell A; Aqvist M
    Vox Sang; 1996; 71(4):221-5. PubMed ID: 8958646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal blood grouping and antibody screening for safe transfusion.
    Makarovska-Bojadzieva T; Blagoevska M; Kolevski P; Kostovska S
    Prilozi; 2009 Jul; 30(1):119-28. PubMed ID: 19736535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of Red Cell Alloantibody among the Transfusion Recipients of Universiti Kebangsaan Malaysia Medical Centre.
    Yousuf R; Abdul Aziz S; Yusof N; Leong CF
    Indian J Hematol Blood Transfus; 2013 Jun; 29(2):65-70. PubMed ID: 24426338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).
    Karafin MS; Tan S; Tormey CA; Spencer BR; Hauser RG; Norris PJ; Roubinian NH; Wu Y; Triulzi DJ; Kleinman S; Gottschall JL; Hendrickson JE
    Transfusion; 2019 Jan; 59(1):217-225. PubMed ID: 30427537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Red cell alloimmunization and infectious marker status (human immunodeficiency virus, hepatitis B virus and hepatitis C virus) in multiply transfused thalassemia patients of North India.
    Makroo RN; Arora JS; Chowdhry M; Bhatia A; Thakur UK; Minimol A
    Indian J Pathol Microbiol; 2013; 56(4):378-83. PubMed ID: 24441225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan.
    Moinuddin I; Fletcher C; Millward P
    J Blood Med; 2019; 10():283-289. PubMed ID: 31692490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and Specificity of RBC Alloantibodies in Indian Patients Attending a Tertiary Care Hospital.
    Zaman S; Chaurasia R; Chatterjee K; Thapliyal RM
    Adv Hematol; 2014; 2014():749218. PubMed ID: 25386192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan.
    Al-Joudi F; Ali AB; Ramli MB; Ahmed S; Ismail M
    Asian J Transfus Sci; 2011 Jan; 5(1):42-5. PubMed ID: 21572715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.